Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:   Director
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   539,056    

Indirect Shares

   247,533      
Direct Value   $43,131,096    

Indirect Value

   $21,938,850      
Total Shares   786,589      
Total Value   $65,069,946      


Biomarin Pharmaceutical Inc $42,098,718 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,680 Incyte Corp $883,876 Immunome Inc. $112,093 Biomarin Pharmaceutical Inc $42,098,718 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,680 Incyte Corp $883,876 Immunome Inc. $112,093
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   -1.0   
   -1.0   
     Percentage Gain/Loss :
   -34.0%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-10 474,994 2024-05-10 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM Director 2023-11-07 7,615 0    Premium*  
* Premium Members only  

Records found :    850         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 33 of 34
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-07-18 4 AS $92.72 $3,863,272 D/D (41,666) 378,584 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-07-18 4 OE $17.54 $730,822 D/D 41,666 420,250 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-08-16 4 AS $91.49 $3,811,868 D/D (41,666) 378,584 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-08-16 4 OE $17.54 $730,822 D/D 41,666 420,250 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-10-17 4 AS $84.39 $3,516,227 D/D (41,666) 323,368 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-10-17 4 OE $17.54 $730,822 D/D 41,666 365,034 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-11-16 4 AS $90.97 $3,790,795 D/D (41,670) 323,368 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-11-16 4 OE $17.54 $730,892 D/D 41,670 365,038 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-09-15 4 OE $17.33 $737,859 D/D 42,577 421,161 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-09-15 4 AS $94.85 $4,038,360 D/D (42,577) 378,584 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-03-22 4 A $0.00 $0 D/D 44,520 235,194 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-02-24 4 A $0.00 $0 D/D 44,671 215,353 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-03-16 4 A $0.00 $0 D/D 44,850 310,341 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-03-01 4 A $0.00 $0 D/D 45,320 333,610 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-02-26 4 A $0.00 $0 D/D 45,722 272,216 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-02-26 4/A A $0.00 $0 D/D 46,034 272,528 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-03-15 4 A $0.00 $0 D/D 46,340 296,106 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-05-12 4 OE $67.81 $3,153,165 D/D 46,500 472,713 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-05-05 4 AS $80.15 $4,007,445 I/I (50,000) 0 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-06-04 4 A $0.00 $0 D/D 50,900 229,157 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-09-29 4 AS $93.65 $4,974,901 D/D (53,125) 378,584 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-09-29 4 OE $38.59 $2,050,094 D/D 53,125 431,709 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-09-30 4 AS $92.02 $4,888,780 D/D (53,125) 378,584 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-09-30 4 OE $38.59 $2,050,094 D/D 53,125 431,709 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-10-13 4 OE $38.59 $2,050,094 D/D 53,125 376,493 0 -
  850  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33  34      
  Page 33 of 34  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us